Sylvianne Schnebert

Title: **Sylvianne Schnebert: Pioneering Patents in Dermatological Innovations**

Introduction

Sylvianne Schnebert, an accomplished inventor based in Olivet, France, has made significant contributions to the field of dermatological and cosmetic science. With a total of five patents, her innovative work focuses primarily on aptamers that demonstrate unique abilities to inhibit key enzymatic activities, providing groundbreaking solutions in skincare.

Latest Patents

Among her latest patents, the invention of aptamers inhibiting the enzymatic activity of the MMP-9 protein stands out. This invention introduces an aptamer with a G-quadruplex structure, capable of effectively inhibiting MMP-9's enzymatic activity, while also suggesting valuable dermatological and cosmetic applications. Another notable patent pertains to the development of a DNA aptamer that inhibits the enzymatic action of tyrosinase, which converts tyrosine into L-DOPA and dopaquinone, again emphasizing its potential in cosmetic and dermatological uses.

Career Highlights

Sylvianne has built her career through notable positions at leading research institutions. She has worked at LVMH Recherche and the Institut National de la Santé et de la Recherche Médicale, where her research efforts have contributed to significant advancements in the understanding and application of aptamers in dermatological science.

Collaborations

Throughout her career, Sylvianne has collaborated with renowned professionals in her field, including Robin Kurfurst and Eric Dausse. These collaborations have played a crucial role in enhancing her research output and have fostered a creative environment for innovation.

Conclusion

Sylvianne Schnebert continues to be a leading force in her domain, with her patents paving the way for novel solutions in skincare. Her dedication to research and collaboration highlights the importance of innovation in improving dermatological products, making her an inspiring figure in the world of inventors and innovators.